These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7550820)

  • 21. Diagnosing hemolytic disease of the newborn.
    Brantley TA
    Clin Lab Sci; 2002; 15(3):140-3. PubMed ID: 12778961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prediction and occurrence of neonatal and fetal hemolytic disease in a 15 year retrospective study of prenatal mother-child serology in Tirol].
    Schönitzer D; Reissigl H
    Beitr Infusionsther; 1988; 21():259-64. PubMed ID: 2462988
    [No Abstract]   [Full Text] [Related]  

  • 23. Characteristics of Bilirubin According to the Results of the Direct Antiglobulin Test and Its Impact in Hemolytic Disease of the Newborn.
    Shin KH; Lee HJ; Song D; Lee SM; Kim IS; Kim H; Yang EJ; Park KH
    Lab Med; 2019 Apr; 50(2):138-144. PubMed ID: 30192966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening for hemolytic disease of the newborn by cord blood Coombs testing--analysis of a five-year experience.
    Clifford JH; Mathews P; Reiquam CW; Palmer HD
    Clin Pediatr (Phila); 1968 Aug; 7(8):465-9. PubMed ID: 4970065
    [No Abstract]   [Full Text] [Related]  

  • 25. Intravenous immunoglobulin G (IVIG) therapy for significant hyperbilirubinemia in ABO hemolytic disease of the newborn.
    Miqdad AM; Abdelbasit OB; Shaheed MM; Seidahmed MZ; Abomelha AM; Arcala OP
    J Matern Fetal Neonatal Med; 2004 Sep; 16(3):163-6. PubMed ID: 15590442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Morbidity of ABO haemolytic disease in the newborn.
    Bhat YR; Kumar CG
    Paediatr Int Child Health; 2012 May; 32(2):93-6. PubMed ID: 22595217
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Limits of routine blood group serology in perinatal diagnosis].
    Wangerin R; Diekamp U
    Beitr Infusionsther; 1990; 26():367-9. PubMed ID: 1703873
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is Cord Blood Bilirubin Level a Reliable Predictor for Developing Significant Hyperbilirubinemia?
    Aktas S; Dogan C; Okmen ZH; Gulec SG
    Am J Perinatol; 2019 Feb; 36(3):317-321. PubMed ID: 30081396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohematology problem.
    Carter S
    Am J Med Technol; 1981 Jun; 47(6):485-6. PubMed ID: 7196694
    [No Abstract]   [Full Text] [Related]  

  • 30. [Value of the Coombs test in ABO incompatibility].
    Bel Comos J; Ribera Crusafont A; Natal Pujol A; Coroleu Lletget W; Pujol Posch N; Prats Viñas J
    An Esp Pediatr; 1991 Oct; 35(4):248-50. PubMed ID: 1763851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reevaluation of the polyvinylpyrrolidone sedimentation test in the diagnosis of ABO hemolytic disease of the newborn.
    Shilo R; Gutman R; Ascari D; Schwartz J
    Vox Sang; 1976; 31(1 SUPPL):16-24. PubMed ID: 1007148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hemolytic disease of the newborn caused by irregular blood subgroup (Kell, C, c, E, and e) incompatibilities: report of 106 cases at a tertiary-care centre.
    Karagol BS; Zenciroglu A; Okumus N; Karadag N; Dursun A; Hakan N
    Am J Perinatol; 2012 Jun; 29(6):449-54. PubMed ID: 22399212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Direct and indirect anti-globulin (Coombs) test].
    Kajiwara M
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():792-4. PubMed ID: 20942191
    [No Abstract]   [Full Text] [Related]  

  • 34. ABO hemolytic disease of the newborn. A retrospective analysis of 254 cases.
    Dufour DR; Monoghan WP
    Am J Clin Pathol; 1980 Mar; 73(3):369-73. PubMed ID: 7189092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [RELATION BETWEEN RETICULOCYTE LEVEL AND DIRECT COOMBS' TEST].
    GUAZELLI C
    Riv Clin Pediatr; 1963 Mar; 71():168-73. PubMed ID: 14076989
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical analysis of seven cases of rare hemolytic disease of the newborn].
    Gu S; Wang HX; Yang CY; Yang XF; Lin Y; Zhong Y; He JP; Wang YJ
    Zhonghua Er Ke Za Zhi; 2018 May; 56(5):369-372. PubMed ID: 29783824
    [No Abstract]   [Full Text] [Related]  

  • 37. Post-test probability for neonatal hyperbilirubinemia based on umbilical cord blood bilirubin, direct antiglobulin test, and ABO compatibility results.
    Peeters B; Geerts I; Van Mullem M; Micalessi I; Saegeman V; Moerman J
    Eur J Pediatr; 2016 May; 175(5):651-7. PubMed ID: 26782094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Percutaneous umbilical blood sampling and umbilical vein transfusions. Rapid serologic differentiation of fetal blood from maternal blood.
    Steiner EA; Judd WJ; Oberman HA; Hayashi RH; Nugent CE
    Transfusion; 1990 Feb; 30(2):104-8. PubMed ID: 2305437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Detection and analysis of ABO Hemolytic disease in newborn].
    Lin ZX; Dong QS
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Oct; 22(5):1432-4. PubMed ID: 25338602
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ABO-haemolytic disease of the newborn (ABO-HDN): factors influencing its severity and incidence in Venezuela.
    Cariani L; Romano EL; Martínez N; Montaño R; Suarez G; Ruiz I; Soyano A
    J Trop Pediatr; 1995 Feb; 41(1):14-21. PubMed ID: 7723123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.